Symptoms and Management of Ectopic Pregnancy
Symptoms of Ectopic Pregnancy
Patients with suspected ectopic pregnancy should be evaluated immediately due to the risk of life-threatening hemorrhage, as ectopic pregnancy accounts for 9% of all maternal deaths. 1
Common presenting symptoms include:
- Abdominal pain (often unilateral)
- Vaginal bleeding (typically lighter than normal menses)
- Amenorrhea or missed period
- Dizziness or syncope (in cases of significant blood loss)
- Shoulder pain (referred pain from diaphragmatic irritation if intraperitoneal bleeding)
- Urge to defecate (from pressure on rectum)
Risk factors that increase suspicion:
- History of pelvic inflammatory disease
- Previous ectopic pregnancy
- Tubal surgery
- Smoking
- Infertility treatment
- Intrauterine device use
Diagnostic Algorithm
Initial Assessment:
- Vital signs (assess for hemodynamic instability)
- Pregnancy test (qualitative β-hCG)
- Pelvic examination (assess for adnexal mass or tenderness)
Transvaginal Ultrasound:
Quantitative β-hCG Testing:
- If ultrasound is indeterminate, quantitative β-hCG helps guide management
- β-hCG >2,000 mIU/mL with no intrauterine pregnancy on transvaginal ultrasound significantly increases likelihood of ectopic pregnancy 2
- Serial β-hCG measurements (48 hours apart) are useful:
- Normal rise in viable intrauterine pregnancy: ≥53% in 48 hours 4
- Abnormal rise or fall: suggestive of ectopic pregnancy
Pregnancy of Unknown Location (PUL):
- Positive pregnancy test but no visible intrauterine or ectopic pregnancy on ultrasound
- Requires close follow-up with serial β-hCG and repeat ultrasound
Management Approach
Immediate Surgical Intervention Required If:
- Hemodynamic instability
- Signs of rupture (acute severe pain, peritoneal signs)
- Fetal cardiac activity detected outside uterus
- High initial β-hCG level (>5,000 mIU/mL) 5, 3
Medical Management with Methotrexate:
Appropriate for stable patients with:
- Unruptured ectopic pregnancy
- β-hCG <5,000 mIU/mL 5
- Adnexal mass ≤3.5 cm 5
- No fetal cardiac activity
- Patient able to comply with follow-up
Methotrexate Protocol:
- Standard dose: 50 mg/m² intramuscularly 5
- Single-dose success rate: approximately 88% 5
- Multiple-dose regimen may be used for higher β-hCG levels (success rate ~93%) 5
Important precautions during methotrexate therapy:
- Avoid folic acid supplements
- Avoid NSAIDs and aspirin due to potential lethal interactions 2
- Monitor for side effects (gastrointestinal symptoms common)
- Rule out ectopic rupture before attributing abdominal pain to methotrexate side effects 2
Follow-up after methotrexate:
- Weekly β-hCG measurements until undetectable (<2 IU/L) 5
- Clinical evaluation for signs of rupture
- Avoid pregnancy for at least 3 months due to teratogenic risk 5
Surgical Management:
- Laparoscopy preferred over laparotomy (unless unstable)
- Options:
- Salpingostomy: tube-conserving procedure for future fertility
- Salpingectomy: removal of fallopian tube (definitive treatment)
Additional Management:
- Administer anti-D immunoglobulin to Rh-negative women 5
- Provide emotional support and counseling
- Discuss future pregnancy risks (10-15% recurrence risk)
Warning Signs Requiring Immediate Attention
- Severe abdominal pain
- Heavy vaginal bleeding
- Dizziness or fainting
- Shoulder pain
- Fever
Key Pitfalls to Avoid
- Relying solely on β-hCG levels without ultrasound in symptomatic patients
- Assuming low β-hCG levels rule out ectopic pregnancy
- Misattributing symptoms of ectopic rupture to methotrexate side effects
- Failing to consider heterotopic pregnancy in patients who underwent fertility treatments
- Delaying treatment in unstable patients for diagnostic certainty
Remember that ectopic pregnancy remains a leading cause of maternal mortality in the first trimester, and early diagnosis and appropriate management are critical to prevent life-threatening complications.